
New Horizons Forum
Speeding the development of new therapies and diagnostics for glaucoma patients.
New Horizons Forum is a full day of presentations, panels, and discussions featuring CEOs from start-up companies, industry executives, health care leaders, venture capitalists, and the FDA. Presented by Glaucoma Research Foundation, the annual catalyst meeting is designed to bring the essential components together to speed the translation of new ideas into clinical practice.
Where & When
Program Agenda
New Horizons Forum unites clinical, industry, financial, and FDA leaders in a unique exchange on research innovation and advances in glaucoma treatment.

“Neuroprotection: the need, the opportunity, the path”
The 2026 Drs. Henry and Frederick Sutro Memorial Lecture will be delivered by pioneering ophthalmic surgeon, prolific inventor, and visionary entrepreneur Dr. Eugene de Juan, Jr.
Eugene de Juan, Jr., MD is the Jean Kelly Stock Distinguished Professor at University of California, San Francisco and Founder and Managing Partner at ForSight Labs, USA. (Speaker Bio)

Do you have a new technology or glaucoma innovation to present?
To submit your application to be a presenting company at New Horizons Forum in 2026, please complete the application.
Nationally and internationally respected leaders in the field of glaucoma, business, and medical innovation provide leadership for the Glaucoma 360 New Horizons Forum. The leadership includes Co-founders Andrew Iwach, MD and Adrienne Graves, PhD, an elite Steering Committee, the New Horizons Advisory Board, and the New Horizons Program Committee.
- Early-stage CEOs and executives
- Business development and other representatives from companies thatoffer pharmaceuticals, devices, drugdelivery, and IOP monitoring
- Clinicians and other key opinion leaders
- Industry executives
- Venture capitalists
- Representatives from clinical research organizations
- Scientific innovators